<?xml version='1.0' encoding='utf-8'?>
<document id="25278668"><sentence text="Alteration of glucose lowering effect of glibenclamide on single and multiple treatments with fenofibrate in experimental rats and rabbit models."><entity charOffset="14-21" id="DDI-PubMed.25278668.s1.e0" text="glucose" /><entity charOffset="41-54" id="DDI-PubMed.25278668.s1.e1" text="glibenclamide" /><entity charOffset="94-105" id="DDI-PubMed.25278668.s1.e2" text="fenofibrate" /><pair ddi="false" e1="DDI-PubMed.25278668.s1.e0" e2="DDI-PubMed.25278668.s1.e0" /><pair ddi="false" e1="DDI-PubMed.25278668.s1.e0" e2="DDI-PubMed.25278668.s1.e1" /><pair ddi="false" e1="DDI-PubMed.25278668.s1.e0" e2="DDI-PubMed.25278668.s1.e2" /><pair ddi="false" e1="DDI-PubMed.25278668.s1.e1" e2="DDI-PubMed.25278668.s1.e1" /><pair ddi="false" e1="DDI-PubMed.25278668.s1.e1" e2="DDI-PubMed.25278668.s1.e2" /></sentence><sentence text="Diabetes mellitus is a syndrome of multiple etiologies" /><sentence text=" Both type 1 and type 2 diabetes lead to multiple abnormalities of lipid and lipoprotein metabolism" /><sentence text=" The aim of this investigation was to study the influence of fenofibrate on the blood glucose lowering effect of glibenclamide"><entity charOffset="61-72" id="DDI-PubMed.25278668.s4.e0" text="fenofibrate" /><entity charOffset="86-93" id="DDI-PubMed.25278668.s4.e1" text="glucose" /><entity charOffset="113-126" id="DDI-PubMed.25278668.s4.e2" text="glibenclamide" /><pair ddi="false" e1="DDI-PubMed.25278668.s4.e0" e2="DDI-PubMed.25278668.s4.e0" /><pair ddi="false" e1="DDI-PubMed.25278668.s4.e0" e2="DDI-PubMed.25278668.s4.e1" /><pair ddi="false" e1="DDI-PubMed.25278668.s4.e0" e2="DDI-PubMed.25278668.s4.e2" /><pair ddi="false" e1="DDI-PubMed.25278668.s4.e1" e2="DDI-PubMed.25278668.s4.e1" /><pair ddi="false" e1="DDI-PubMed.25278668.s4.e1" e2="DDI-PubMed.25278668.s4.e2" /></sentence><sentence text="" /><sentence text="Glibenclamide (0"><entity charOffset="0-13" id="DDI-PubMed.25278668.s6.e0" text="Glibenclamide" /></sentence><sentence text="45, 0" /><sentence text="23 mg/kg) and fenofibrate (18"><entity charOffset="14-25" id="DDI-PubMed.25278668.s8.e0" text="fenofibrate" /></sentence><sentence text="1, 9" /><sentence text="38 mg/kg) was treated to normal, diabetic rats, and normal rabbits" /><sentence text=" Blood samples were collected at various time intervals and were analyzed for blood glucose levels using a glucometer"><entity charOffset="84-91" id="DDI-PubMed.25278668.s11.e0" text="glucose" /></sentence><sentence text="" /><sentence text="Co-administration of fenofibrate with glibenclamide significantly elevated the blood glucose reduction exhibited by glibenclamide"><entity charOffset="21-32" id="DDI-PubMed.25278668.s13.e0" text="fenofibrate" /><entity charOffset="38-51" id="DDI-PubMed.25278668.s13.e1" text="glibenclamide" /><entity charOffset="85-92" id="DDI-PubMed.25278668.s13.e2" text="glucose" /><entity charOffset="116-129" id="DDI-PubMed.25278668.s13.e3" text="glibenclamide" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e0" e2="DDI-PubMed.25278668.s13.e0" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e0" e2="DDI-PubMed.25278668.s13.e1" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e0" e2="DDI-PubMed.25278668.s13.e2" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e0" e2="DDI-PubMed.25278668.s13.e3" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e1" e2="DDI-PubMed.25278668.s13.e1" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e1" e2="DDI-PubMed.25278668.s13.e2" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e1" e2="DDI-PubMed.25278668.s13.e3" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e2" e2="DDI-PubMed.25278668.s13.e2" /><pair ddi="false" e1="DDI-PubMed.25278668.s13.e2" e2="DDI-PubMed.25278668.s13.e3" /></sentence><sentence text="" /><sentence text="The results obtained from single and multiple dose treatments clearly demonstrated the existence of drug-drug interaction at the dose tested in animal models" /><sentence text=" Hence, this investigation would serve as a preclinical evidence for the effect of fenofibrate on the therapeutic efficacy of glibenclamide"><entity charOffset="83-94" id="DDI-PubMed.25278668.s16.e0" text="fenofibrate" /><entity charOffset="126-139" id="DDI-PubMed.25278668.s16.e1" text="glibenclamide" /><pair ddi="false" e1="DDI-PubMed.25278668.s16.e0" e2="DDI-PubMed.25278668.s16.e0" /><pair ddi="false" e1="DDI-PubMed.25278668.s16.e0" e2="DDI-PubMed.25278668.s16.e1" /></sentence><sentence text="" /></document>